跳至主要内容
临床试验/ISRCTN16562415
ISRCTN16562415已完成未知

The impact of dietary interventions for irritable bowel syndrome on luminal microbiota, symptoms, nutrient intake and quality of life: a randomised controlled trial

King's College London0 个研究点目标入组 69 人开始时间: 2015年3月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
69

研究概览

简要总结

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32433273/ results (added 07/08/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Men and women aged 18-65 years with diarrhoea-predominant IBS (IBS-D), mixed-type IBS (IBS-M) or unsubtyped IBS (IBS-U) based on Rome III criteria who do not have a major medical condition (diabetes, psychiatric or current eating disorders), gastrointestinal disease (e.g. inflammatory bowel disease, coeliac disease) or history of previous GI surgery, except cholecystectomy and haemorrhoidectomy
  • 2. Individuals able to give informed consent
  • 3. Individuals naive to the dietary intervention

排除标准

  • 1. Females who report to be pregnant or lactating
  • 2. Consumption of antibiotics, prebiotics or probiotics (in food products or as supplements) in the last 4 weeks prior to, or during the study
  • 3. Use of unpermitted medications
  • 4. Participants who have received bowel preparation for investigative procedures in the 4 weeks prior to the study
  • 5. Participants who have had changes to IBS medications or dose in the 4 weeks prior to the study
  • 6. Less than 2 days of at least moderate abdominal pain or discomfort in the screening week
  • 7. Individuals with additional specific dietary needs
  • 8. Individuals with excess alcohol or caffeine intake as assessed by diet questionnaires as these substances may confound symptom results

研究者

相似试验